An open-label, phase 1 study to evaluate the effects of hepatic impairment on edoxaban pharmacokinetics and pharmacodynamics
Author:
Affiliation:
1. Daiichi Sankyo Pharma Development; Edison NJ USA
2. Allergan Ltd.; Buckinghamshire UK
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.550/fullpdf
Reference40 articles.
1. DU-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles;Furugohri;J Thromb Haemost.,2008
2. Edoxaban versus warfarin in patients with atrial fibrillation;Giugliano;N Engl J Med.,2013
3. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism;The Hokusai VTE;N Engl J Med.,2013
4. ® 2014
5. 2015
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH;Journal of Thrombosis and Haemostasis;2024-09
2. Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling;International Journal of Molecular Sciences;2024-08-10
3. Direct oral anticoagulants in cirrhosis: Rationale and current evidence;JHEP Reports;2024-08
4. Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis;Scientific Reports;2024-05-11
5. Effectiveness and safety of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease: A multinational cohort study;Thrombosis Research;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3